FindMyKOL

Barry Rutherford, MD

Basic profile

University of Missouri–Kansas City

ORCIDNone on fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionKansas City, MO · MidwestSpecialtyInterventional CardiologyFocusCardiology
Last active 2011FindMyKOL type: RegionalLatest publication2011Online presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Barry Rutherford is a Cardiology physician affiliated with University of Missouri–Kansas City. OpenAlex indexes 126 publications with 7,792 citations (h-index 45). By OpenAlex citation count, this profile ranks in the top 10% of Interventional Cardiology profiles in the FindMyKOL directory.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
126publications

Publications indexed by OpenAlex. Counts exclude supporting files.

7,792citations

Citations across these publications.

45h-index

H-index from these publications.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    93.8%
    Beta blocker28%
    Metoprolol Succinate44%Carvedilol35%Metoprolol Tartrate21%
    Part D<11 patients
    Statin26.5%
    Atorvastatin Calcium79%Rosuvastatin Calcium11%Simvastatin10%
    Part D<11 patients

    + 7 more classes in this area

  • Blood & clotting

    3.2%
    P2Y12 inhibitor3.2%
    Clopidogrel100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    3%
    Proton pump inhibitor3%
    Pantoprazole Sodium100%
    Part D<11 patients
Where care is delivered (Part B), 20220% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”